Inactive Instrument
Celator Pharmaceuticals Inc Stock
Stocks
US15089R1023
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 16-05-31 | Celator Pharmaceuticals : Jazz Pharma to buy Celator in $1.5 billion deal | RE |
| 16-05-31 | Celator Pharmaceuticals : Jazz Pharma nears deal to buy Celator for about $1.5 billion - WSJ | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
Arthur C. Louie
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.64% | +6.45% | +12.39% | +38.40% | 47.97B | |
| +0.34% | +0.58% | +50.21% | +37.31% | 44.5B | |
| -0.90% | +5.62% | +341.91% | +620.93% | 43.93B | |
| +1.64% | +0.16% | +10.04% | +98.87% | 41.03B | |
| +0.51% | -0.61% | +5.18% | +46.87% | 29.85B | |
| -0.06% | -0.79% | +23.67% | +151.37% | 17.27B | |
| +0.35% | +8.63% | +7.88% | - | 15.34B | |
| +1.76% | +0.85% | +29.47% | +48.42% | 15.3B | |
| +1.99% | -3.12% | - | - | 14.82B | |
| Average | +0.90% | +2.46% | +60.09% | +148.88% | 30B | |
| Weighted average by Cap. | +0.87% | +2.97% | +76.01% | +165.06% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
